About Intensity Therapeutics
Intensity Therapeutics is a company based in Westport (United States) founded in 2012. It operates as a HealthTech. Intensity Therapeutics has raised $20.98 million across 6 funding rounds from investors including Fastforward Innovations, SalvaRx and VCapital. The company has 16 employees as of December 31, 2024. Intensity Therapeutics offers products and services including INT230-6 and DfuseRx℠.
- Headquarter Westport, United States
- Employees 16 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Intensity Therapeutics, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-16.27 M-54.37as on Dec 31, 2024
-
EBITDA
$-16.56 M-102.64as on Dec 31, 2024
-
Total Equity Funding
$20.98 M (USD)
in 6 rounds
-
Latest Funding Round
$6.5 M (USD), Series B
Nov 02, 2018
-
Investors
Fastforward Innovations
& 3 more
-
Employee Count
16
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Intensity Therapeutics
Intensity Therapeutics is a publicly listed company on the NASDAQ with ticker symbol INTS in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Intensity Therapeutics
Intensity Therapeutics offers a comprehensive portfolio of products and services, including INT230-6 and DfuseRx℠. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A drug designed to kill tumors and activate immunity.
A platform enhancing drug absorption in solid tumors.
Unlock access to complete
Unlock access to complete
Funding Insights of Intensity Therapeutics
Intensity Therapeutics has successfully raised a total of $20.98M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $6.5 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series B — $6.5M
-
First Round
First Round
(26 Feb 2013)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2018 | Amount | Series B - Intensity Therapeutics | Valuation |
investors |
|
| Jun, 2016 | Amount | Series A - Intensity Therapeutics | Valuation |
investors |
|
| Apr, 2016 | Amount | Series A - Intensity Therapeutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Intensity Therapeutics
Intensity Therapeutics has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Fastforward Innovations, SalvaRx and VCapital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment opportunities are provided for accredited investors.
|
Founded Year | Domain | Location | |
|
Venture capital investment opportunities are provided for accredited investors.
|
Founded Year | Domain | Location | |
|
Tech & life Science focused early stage VC firm investing in North America & Europe
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Intensity Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Intensity Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Intensity Therapeutics Comparisons
Competitors of Intensity Therapeutics
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Intensity Therapeutics
Frequently Asked Questions about Intensity Therapeutics
When was Intensity Therapeutics founded?
Intensity Therapeutics was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Where is Intensity Therapeutics located?
Intensity Therapeutics is headquartered in Westport, United States.
Is Intensity Therapeutics a funded company?
Intensity Therapeutics is a funded company, having raised a total of $20.98M across 6 funding rounds to date. The company's 1st funding round was a Series A of $2M, raised on Feb 26, 2013.
How many employees does Intensity Therapeutics have?
As of Dec 31, 2024, the latest employee count at Intensity Therapeutics is 16.
What does Intensity Therapeutics do?
Intensity Therapeutics is engaged in creating innovative cancer treatments through intratumoral delivery technology. The companys approach is centered on killing cancer cells while activating systemic immune responses. Solutions are developed for metastatic and presurgical patients to extend life and prevent recurrence. The healthcare sector, specifically oncology, is the primary focus of their research and clinical trials.
What products or services does Intensity Therapeutics offer?
Intensity Therapeutics offers INT230-6 and DfuseRx℠.
Is Intensity Therapeutics publicly traded?
Yes, Intensity Therapeutics is publicly traded on NASDAQ under the ticker symbol INTS.
Who are Intensity Therapeutics's investors?
Intensity Therapeutics has 4 investors. Key investors include Fastforward Innovations, SalvaRx, VCapital, and VCapital.
What is Intensity Therapeutics's ticker symbol?
The ticker symbol of Intensity Therapeutics is INTS on NASDAQ.